indomethacin ethyl ester has been researched along with indomethacin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crews, BC; Kalgutkar, AS; Marnett, AB; Marnett, LJ; Remmel, RP | 1 |
| Cruz, L; da Silveira, NP; Guterres, SS; Pohlmann, AR; Soares, LU | 1 |
| Costa, TD; Cruz, L; da Silveira, NP; Guterres, SS; Mezzalira, G; Pohlmann, AR; Soares, LU | 1 |
| Battastini, AM; Bavaresco, L; Bernardi, A; Figueiró, F; Frozza, RL; Guterres, SS; Jäger, E; Pohlmann, AR; Salbego, C | 1 |
| Cattani, VB; Dalla Costa, T; Pohlmann, AR | 1 |
| Cattani, VB; Colomé, LM; Dalla Costa, T; Fiel, LA; Guterres, SS; Jäger, A; Jäger, E; Pohlmann, AR; Stefani, V; Uchoa, F | 1 |
| Farsky, SH; Fiel, LA; Guterres, SS; Pereira, NR; Pohlmann, AR; Rodrigues, SF; Shimada, AL | 1 |
7 other study(ies) available for indomethacin ethyl ester and indomethacin
| Article | Year |
|---|---|
Ester and amide derivatives of the nonsteroidal antiinflammatory drug, indomethacin, as selective cyclooxygenase-2 inhibitors.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Humans; Indomethacin; Isoenzymes; Macrophages; Membrane Proteins; Mice; Prostaglandin-Endoperoxide Synthases; Sheep; Structure-Activity Relationship | 2000 |
Alkaline hydrolysis as a tool to determine the association form of indomethacin in nanocapsules prepared with poly(eta-caprolactone).
Topics: Anti-Inflammatory Agents, Non-Steroidal; Capsules; Drug Carriers; Drug Compounding; Ethanol; Hydrolysis; Indomethacin; Nanotechnology; Particle Size; Polyesters; Triglycerides | 2004 |
Diffusion and mathematical modeling of release profiles from nanocarriers.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chemistry, Pharmaceutical; Crystallography, X-Ray; Diffusion; Drug Carriers; Indomethacin; Models, Chemical; Models, Theoretical; Nanotechnology; Oils; Polyesters; Polymers; Solubility; Technology, Pharmaceutical | 2006 |
Selective cytotoxicity of indomethacin and indomethacin ethyl ester-loaded nanocapsules against glioma cell lines: an in vitro study.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Brain Neoplasms; Cell Count; Cell Line, Tumor; Cell Survival; Chemical Phenomena; Chemistry, Physical; Coloring Agents; Cyclooxygenase 2 Inhibitors; Drug Compounding; Glioma; Hippocampus; Humans; Hydrogen-Ion Concentration; Indomethacin; Male; Nanocapsules; Organ Culture Techniques; Propidium; Rats; Rats, Wistar; Suspensions | 2008 |
Pharmacokinetic evaluation of indomethacin ethyl ester-loaded nanoencapsules.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biotransformation; Drug Compounding; Indomethacin; Injections, Intravenous; Male; Models, Biological; Nanocapsules; Prodrugs; Rats; Rats, Wistar | 2008 |
Lipid-core nanocapsules restrained the indomethacin ethyl ester hydrolysis in the gastrointestinal lumen and wall acting as mucoadhesive reservoirs.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Drug Carriers; Fluorescent Dyes; Hydrolysis; Indomethacin; Intestinal Absorption; Intestinal Mucosa; Male; Models, Animal; Nanocapsules; Rats; Rats, Wistar; Tissue Adhesives; Tissue Distribution | 2010 |
Lipid-Core Nanocapsules Act as a Drug Shuttle Through the Blood Brain Barrier and Reduce Glioblastoma After Intravenous or Oral Administration.
Topics: Administration, Oral; Animals; Blood-Brain Barrier; Brain; Brain Neoplasms; Cell Line, Tumor; Disease Progression; Female; Fluorescein-5-isothiocyanate; Glioblastoma; Indomethacin; Injections, Intravenous; Lipids; Mice, Inbred C57BL; Microvessels; Nanocapsules; Particle Size; Platelet Adhesiveness; Rhodamines; Spectrometry, Fluorescence; Tumor Burden | 2016 |